Observational studyThe Korean journal of internal medicine2025
Efficacy and safety of first-line afatinib in older patients with advanced EGFR-mutated non-small cell lung cancer.
Mi-Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.